5D Library › Books › 5DL-B-054
亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型
从前药脱乙醯基米氏动力学、全脑功能连接熵增到微剂量耐受棘轮及古典本草「轻身延年」剂量边界考辨
Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics: From Michaelis–Menten Kinetics of Prodrug Deacetylation and Whole-Brain Connectivity Entropy to the Microdose Tolerance Ratchet, with a Textual Examination of the Dose Boundary in the Classical Materia Medica
DOI10.5281/zenodo.24019347摘要
本书是教学与研究用的生物数学与方法学讨论,**不是医疗建议,也不是任何物质的使用指南**。本书讨论的物质在多数司法辖区受管制;书中**不给出任何剂量、质量、产品、来源、途径、合成或疗程**:全书的剂量一律以相对于一个未指定参考值的无量纲比值表示,这是第 8 本确立的写法。
本书把「亚知觉微剂量」所依赖的药理链条写成数学,并逐段检验。受体占据遵循希尔关系,其对数斜率从 1 平滑地降到 0,所以没有哪个暴露量「因为受体的缘故」是亚知觉的——阈值只能由知觉给出。前药的饱和转化并不使总暴露跳升:质量守恒把曲线下面积固定住,饱和改变的只是**形状**——未饱和时十倍剂量使峰值升高 7.84 倍;饱和时只升高 3.49 倍,而达峰时间拉长 6.40 倍。由单一暴露的曲线拟合,米氏常数只能定到 13 倍以内,五倍暴露下的峰值预测却只差 1.31 倍;真正的障碍是人体转化动力学根本没有发表,这使峰值的不确定度扩大到 6.13 倍。「亚知觉」是一个人群分布而不是一个剂量。受体下调的「耐受棘轮」取决于一个从未在人体测量过的恢复半衰期,而较密的日程使**每次**效应下降、**累计**效应上升。连接熵的上升与额外噪声不可区分:跨 20 个脑区使熵升高 1 比特只需约 4.6% 的额外噪声方差。可塑性「窗口」是闸门而非驱动。
第七章把《神农本草经》的递增规则当作一个剂量探索**算法**,与 3+3 设计及连续重估法比较,指出风险主要来自最后的「十之」一步。第八章给出四步核查表与一项预注册双盲试验:最小关注效应 0.30 个标准差,每臂随机 282 例,共 564 例,设盲完整性写入判定规则。书中以标注框区分已发表的证据、可运行的 Python 计算(16 段程序)、原典与作者的模型和假说;除注明的文献数据外,书中数据都是合成的。
关键词:药代动力学;药效动力学;米氏动力学;前药转化;效应室;希尔方程;受体占据;5-HT2A 受体;受体下调;耐受;微剂量;自盲法试验;预期效应;设盲完整性;功能连接熵;熵脑;头动混淆;神经可塑性;关键期;TrkB;剂量探索;毒物兴奋效应;结构可识别性;预注册
Abstract
This book presents biomathematics and methodology for teaching and research. It is **not medical advice and is not a guide to using anything**. The substances it discusses are controlled in most jurisdictions, and the book gives **no dose, mass, product, source, route, synthesis or course of use**: every amount is a dimensionless ratio to an unspecified reference, the convention established in Volume 8.
The book writes the pharmacological chain behind "sub-perceptual microdosing" as mathematics and tests it link by link. Receptor occupancy follows the Hill relation, whose log-log slope falls smoothly from 1 to 0, so no exposure is sub-perceptual by virtue of the receptor; a threshold can only be imposed by perception. Saturating a prodrug's conversion does not make total exposure jump: mass balance fixes the area under the curve and saturation changes only the **shape** — unsaturated, a tenfold amount raises the peak 7.84-fold; saturated, only 3.49-fold, while the time to peak stretches 6.40-fold. Fitting one exposure's curve pins the Michaelis constant only to within a factor of 13 yet predicts the peak at a fivefold exposure to within a factor of 1.31; the real obstacle is that no human conversion kinetics are published, which widens the peak uncertainty to a factor of 6.13. "Sub-perceptual" is a population distribution, not a dose. The receptor-downregulation "tolerance ratchet" depends on a recovery half-life never measured in humans, and a tighter schedule lowers the effect **per dose** while raising the **cumulative** effect. A rise in connectivity entropy is indistinguishable from added noise: 1 bit across 20 regions needs only about 4.6 % added noise variance. A plasticity "window" is a gate, not a drive.
Chapter 7 treats the Shennong Bencao Jing's escalation rule as a dose-finding **algorithm**, compares it with a 3+3 design and a continual reassessment method, and finds that its final tenfold step carries most of the risk. Chapter 8 gives a four-step checklist and a pre-registered double-blind trial: smallest effect of interest 0.30 SD, 282 randomised per arm, 564 in all, with blind integrity written into the decision rule. Marked boxes separate published evidence, runnable Python calculations (16 programs), classical sources and the author's models and hypotheses; apart from cited literature data, all data in the book are synthetic.
Keywords: pharmacokinetics; pharmacodynamics; Michaelis-Menten kinetics; prodrug conversion; effect compartment; Hill equation; receptor occupancy; 5-HT2A receptor; receptor downregulation; tolerance; microdosing; self-blinding trial; expectancy effect; blinding integrity; functional connectivity entropy; entropic brain; head motion confound; neuroplasticity; critical period; TrkB; dose-finding; hormesis; structural identifiability; pre-registration
目录 · Contents
- 序:把一条药理链条写成数学English 中文Preface: Writing a Pharmacological Chain as Mathematics
- 第一章 受体占据:没有拐点,所以没有阈值English 中文Chapter 1. Receptor Occupancy: No Corner, Therefore No Threshold
- 第二章 前药与饱和转化:饱和削平峰值English 中文Chapter 2. Prodrugs and Saturable Conversion: Saturation Blunts the Peak
- 第三章 药代—药效耦合:知觉阈不是一个数English 中文Chapter 3. Coupling Kinetics to Effect: The Perceptual Threshold Is Not a Number
- 第四章 受体下调与耐受棘轮:每次下降,累计上升English 中文Chapter 4. Downregulation and the Tolerance Ratchet: Each Dose Less, the Total More
- 第五章 连接熵:与噪声不可区分English 中文Chapter 5. Connectivity Entropy: Indistinguishable from Noise
- 第六章 可塑性窗口:闸门,不是驱动English 中文Chapter 6. The Plasticity Window: A Gate, Not a Drive
- 第七章 原典并读:「先起如黍粟」与剂量的边界English 中文Chapter 7. Classical Sources Read Side by Side: "Begin Like a Millet Grain" and the Boundary of Dose
- 第八章 实践与预注册检验English 中文Chapter 8. Practice and a Pre-Registered Test
How to cite · 引用
Fan, Y. (2026). Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics: From Michaelis–Menten Kinetics of Prodrug Deacetylation and Whole-Brain Connectivity Entropy to the Microdose Tolerance Ratchet, with a Textual Examination of the Dose Boundary in the Classical Materia Medica [亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型] (Version 1.0.0). 5D Library. https://doi.org/10.5281/zenodo.24019347
BibTeX
@book{fan2026tryptamine,
title = {{Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics}: From Michaelis–Menten Kinetics of Prodrug Deacetylation and Whole-Brain Connectivity Entropy to the Microdose Tolerance Ratchet, with a Textual Examination of the Dose Boundary in the Classical Materia Medica},
author = {Fan, Yafu},
year = {2026},
publisher = {5D Library},
edition = {Version 1.0.0},
doi = {10.5281/zenodo.24019347},
url = {https://doi.org/10.5281/zenodo.24019347},
note = {Chinese title: 亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型}
}
| DOI | https://doi.org/10.5281/zenodo.24019347 |
|---|---|
| DOI(全部版本 all versions) | https://doi.org/10.5281/zenodo.24019346 |
| ORCID | https://orcid.org/0009-0004-3519-1203 |
| 5D Library ID | 5DL-B-054 |
| 版本 Version | 1.0.0 · 中英双语版 Bilingual edition |
| 出版日期 Date | 2026-11-06 |
| 网址 Online | https://5dlibrary.com/books/tryptamine-pharmacokinetics-5ht2a-desensitisation/ |
| SHA-256 · tryptamine-pharmacokinetics-5ht2a-desensitisation_bilingual_v1.0.0.pdf | d4332a7a9c4a49c8c9eb4c6b0381bc2d1a00b96bfafb2616d4a33028bfb9f00d |
| SHA-256 · tryptamine-pharmacokinetics-5ht2a-desensitisation_en_v1.0.0.pdf | 86e88b9d1d6dfe0378158373f1281db6a026626959e6d3a802a25bc203143b95 |
| SHA-256 · tryptamine-pharmacokinetics-5ht2a-desensitisation_zh_v1.0.0.pdf | 5e057e298d3986d140a9a287b05dc2e478f2cd8ec8945b685a22e38d90102f45 |
| Licence · 许可 | Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Disclosure. The author uses the works of 5D Library, including this book, as the methodological basis of his community courses, the 5D Ascension Cards (Dimensional Shift Card Decks) and the Yafu AI knowledge base, and therefore has a commercial interest in the subject of this book. The group also operates ketohackers.com and nadplusnadplus.com, two health-education sites adjacent to this book's metabolic and plasticity themes; this book links to neither and mentions no product. The book promotes no course, card deck, substance or service, gives no dose, source, route or course of use, and explicitly does not recommend that anyone use any substance it discusses; the Chapter 8 trial is designed to be run and analysed by researchers independent of the author's business, in a jurisdiction where the required regulatory authorisation has been obtained, and does not recruit from the author's community, students or customers; all the code and the study protocol are published openly for anyone to check. The author provides no medical services and sells no substance, device, supplement or test.